Item 7.01 Regulation FD Disclosure.

On May 30, 2023, Biofrontera Inc. (the "Company") issued a press release announcing the appointment of Hermann Luebbert as its chief executive officer, a copy of which is attached here as Exhibit 99.1.

The information in Item 7.01 of this Current Report is being furnished and shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

99.1 Press release dated May 30, 2023

Cover Page Interactive Data File (the cover page XBRL tags are embedded 104 within the inline XBRL document)

© Edgar Online, source Glimpses